We tested additional features of the cell lines for their influence on BAF proliferation: source of cell line (primary breast cancer, pleural effusion), tumor type (adenocarcinoma, invasive ductal carcinoma, ductal carcinoma), and (over)expression or mutation of cellular tumor antigen p53 (TP53). This evidence concerns the gene TP53 and breast ductal adenocarcinoma.